CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells

Title
CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cells
Authors
Keywords
CD147, HER2, breast cancer, antibody drug resistance/sensitivity, trastuzumab efficacy
Journal
Oncotarget
Volume 7, Issue 36, Pages -
Publisher
Impact Journals, LLC
Online
2016-06-24
DOI
10.18632/oncotarget.10252

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now